Increased FDG uptake in association with reduced extremity fat in HIV patients

Antiviral Therapy

Volumn 18, Issue 2, 2013, Pages 243-248

  Torriani, Martin ^a   Zanni, Markella V ^a   Fitch, Kathleen ^a   Stavrou, Eleni ^a   Bredella, Miriam A ^a   Lim, Ruth ^a   Cypess, Aaron M ^b   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYTIC METHOD; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; HIV ASSOCIATED LIPODYSTROPHY; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERINSULINEMIA; IMMUNOLOGICAL PARAMETERS; IMMUNOPHENOTYPING; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; LIPOATROPHY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCUTANEOUS FAT; TREATMENT DURATION; WHOLE BODY CT; WHOLE BODY PET;

ABDOMINAL FAT; BODY COMPOSITION; EXTREMITIES; FLUORODEOXYGLUCOSE F18; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SUBCUTANEOUS FAT;

EID: 84875677881     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2420     Document Type: Article

References (20)

1. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352:48-62.
2. Chen D, Misra A, Garg A. Clinical review 153: lipodystrophy in human immunodeiciency virus-infected patients. J Clin Endocrinol Metab 2002; 87:4845-4856.
3. Domingo P, Matias-Guiu X, Pujol RM, et al. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 1999; 13:2261-2267.
4. Hammond E, McKinnon E, Nolan D. Human immunodeiciency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. Clin Infect Dis 2010; 51:591-599.
5. Shikuma CM, Hu N, Milne C, et al. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 2001; 15:1801-1809.
6. Giralt M, Domingo P, Villarroya F. Adipose tissue biology and HIV-infection. Best Pract Res Clin Endocrinol Metab 2011; 25:487-499.
7. Sevastianova K, Sutinen J, Kannisto K, Hamsten A, Ristola M, Yki-Jarvinen H. Adipose tissue inlammation and liver fat in patients with highly active antiretroviral therapyassociated lipodystrophy. Am J Physiol Endocrinol Metab 2008; 295:E85-E91.
8. Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dolan S, Grinspoon S. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol 2006; 100:609-614.
9. Hadigan C, Kamin D, Liebau J, et al. Depot-speciic regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Am J Physiol Endocrinol Metab 2006; 290:E289-E298.
10. Bleeker-Rovers CP, van der Ven AJ, Zomer B, et al. F-18-luorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. AIDS 2004; 18:2430-2432.
11. Torriani M, Fitch K, Stavrou E, et al. Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. J Clin Endocrinol Metab 2012; 97:E602-E607.
12. Christen T, Sheikine Y, Rocha VZ, et al. Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. JACC Cardiovasc Imaging 2010; 3:843-851.
13. Westergren H, Danielsson A, Nystrom FH, Stralfors P. Glucose transport is equally sensitive to insulin stimulation, but basal and insulin-stimulated transport is higher, in human omental compared with subcutaneous adipocytes. Metabolism 2005; 54:781-785.
14. O'Rourke RW, Metcalf MD, White AE, et al. Depot-speciic differences in inlammatory mediators and a role for NK cells and IFN-gamma in inlammation in human adipose tissue. Int J Obes (Lond) 2009; 33:978-990.
15. Klimcakova E, Roussel B, Kovacova Z, et al. Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia 2011; 54:876-887.
16. Klimcáková E, Roussel B, Marquez-Quinones A, et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J Clin Endocrinol Metab 2011; 96:E73-E82.
17. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 1995; 270:29083-29089.
18. Lumeng CN, Deyoung SM, Saltiel AR. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007; 292:E166-E174.
19. Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC. Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy. J Acquir Immune Deic Syndr 2000; 25:312-321.
20. Lake JE, Wohl D, Scherzer R, et al. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care 2011; 23:929-938.